Evidence map›Paper›PMID 27651398›Full record

ArticleAnnals of the rheumatic diseases2017

Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.

Iago Pinal-Fernandez, Maria Casal-Dominguez, John A Carrino, Arash H Lahouti, Pari Basharat, Jemima Albayda, Julie J Paik, Shivani Ahlawat, Sonye K Danoff, Thomas E Lloyd and 2 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Annals of the rheumatic diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 193 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Observational

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Iago Pinal-FernandezNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Maria Casal-DominguezJohns Hopkins University School of Medicine, Baltimore, Maryland, USA.
John A CarrinoJohns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID http://orcid.org/0000-0003-3472-2469
Arash H LahoutiJohns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Pari BasharatJohns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jemima AlbaydaJohns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Julie J PaikJohns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Shivani AhlawatJohns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sonye K DanoffJohns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Thomas E LloydJohns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Andrew L MammenNational Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Lisa Christopher-StineJohns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Johns Hopkins University · USNational Institutes of Health · US

Funding

Muscle Disease UnitZIAAR041203 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI MAMMEN, ANDREW · 2015 to 2025
$19.7M
Intramural NIH HHS Z99 AR999999
6 · The paper itself

Abstract

objectivesThe aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoantibodies.

methodsAll Johns Hopkins Myositis Longitudinal Cohort subjects with a thigh MRI (tMRI) who fulfilled criteria for IMNM, dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) or clinically amyopathic DM (CADM) were included in the study. Muscles were assessed for intramuscular and fascial oedema, atrophy and fatty replacement. Disease subgroups were compared using univariate and multivariate analyses. Patients with IMNM with anti-signal recognition particle (SRP) autoantibodies were compared with those with IMNM with anti-HMG-CoA reductase (HMGCR) autoantibodies.

resultsThe study included 666 subjects (101 IMNM, 176 PM, 219 DM, 17 CADM and 153 IBM). Compared with DM or PM, IMNM was characterised by a higher proportion of thigh muscles with oedema, atrophy and fatty replacement (p<0.01). Patients with IMNM with anti-SRP had more atrophy (19%, p=0.003) and fatty replacement (18%, p=0.04) than those with anti-HMGCR. In IMNM, muscle abnormalities were especially common in the lateral rotator and gluteal groups. Fascial involvement was most widespread in DM. Fatty replacement of muscle tissue began early during the course of disease in IMNM and the other groups. An optimal combination of tMRI features had only a 55% positive predictive value for diagnosing IMNM.

conclusionsCompared with patients with DM or PM, IMNM is characterised by more widespread muscle involvement. Anti-SRP-positive patients have more severe muscle involvement than anti-HMGCR-positive patients.

Indexed as

Magnetic Resonance ImagingAdiposityAdultAgedAntibodiesAtrophyBiomarkersDermatomyositisEdemaFemaleHumansHydroxymethylglutaryl CoA ReductasesMaleMiddle AgedMuscle, SkeletalMuscular DiseasesAntibodiesBiomarkersHMGCR protein, humanHydroxymethylglutaryl CoA ReductasesSignal Recognition ParticleAutoantibodiesDermatomyositisMagnetic Resonance ImagingPolymyositis

Identifiers

PMID27651398
PMCPMC6019551
OpenAlexW2523293821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.